Article
Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer
10 Oct 2023
Abstract excerpt
Background: Prostate cancer, the second most prevalent malignancy among men, poses a significant threat to affected patients' well-being due to its poor prognosis. Novel biomarkers are required to enhance clinical outcomes and tailor personalized treatments. Herein, we describe our research to explore the prognostic value of long non-coding RNAs (lncRNAs) deregulated by copy number variations (CNVs) in prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
